is a popular medicinal website in Bangladesh.

Advanced Technology in Bangladesh Pharmaceutical Industries

Technological advancement in pharmaceutical industry can improve the speed, performance and results of the company goals. Competitive and technological advancing of pharmaceutical industry in innovative R&D partnerships and marketing plans are reshaping the business strategies of many pharmaceutical and biotechnology companies.

According to new research from the MIT Program on the Pharmaceutical Industry (POPI), 'many companies today are searching for ways to increase productivity, decrease costs, and develop new treatment modalities that will enhance profitability'.

In Bangladesh, pharmaceuticals industries are the soul of healthcare sector. Comparing with other sectors it is the most technologically advanced sector of Bangladesh. The Pharmaceuticals industries have grown and developed notably in the last two decades. During these decades pharmaceutical sector achieved a lofty position in international and local market. Pharmaceutical companies fulfill more than 97% of regional demand of medicines and about 30 companies export a significant quantity of medicines to 107 countries, including USA, UK, Germeny, France, Italy, Canada, Netherlands and Denmark. International regulatory authorities like US-FDA, UK-MHRA, Australia-TGA, EU have already certified some pharmaceutical companies and soon some others are going to be certified and approved.

Though pharmaceutical industries in Bangladesh are showing their competitive performance by assuring proper qualities with GMP, CGMP guidelines to manufacture drugs in local and global market, they should be more advanced in technology to be listed on top tier world class pharmaceutical companies. There are some improvements have needed to be more advanced in following sector -

Drug Development

In Bangladesh, no pharmaceutical companies exactly work on drug development but they change and modify the formulation for better action. On the otherhand the continuing evolution of new technologies, such as 3-D biological printing, ultra-high-resolution analytical instruments, next-generation sequencing, desktop electron microscopy, gene therapy, translational research, stem cell therapies and microbiomics are changing the traditional rules for drug development, as well as the FDA (Food and Drug Administration) changing its own rules. Bangladesh National Formulary should be proposed this advanced technology in Bangladeshi drug industries to apply in drug development for getting some extra advantages.

Manufacturing Development

Recent trends facing the pharmaceutical industry in Bangladesh pose numerous challenges to manufacturers. FDA is working with drug makers in a new way to help the industry adopt scientifically sound, novel technologies to produce quality medicines that are consistently safe and effective.

FDA strives to support the modernization of pharmaceutical manufacturing by providing guidance to drug companies that are pursuing new technologies. One example is the recent approval of the first ever 3D printed pill which was for Spritam (levetiracetam), a medication to treat epilepsy. In this case, FDA worked closely with the manufacturer to make 3D printing technology a reality.

The structure and composition of functional coating of pharmaceutical products is critical and manufacturing these products presents a challenge to the pharmaceutical industry. So pharmaceutical companies should be develop novel sensing techniques and intelligent feedback loops which will be automatic measurement system and greater control of pharmaceutical coating process.

A pharmaceutical company always needs a good communication with the suppliers of research and development and production equipment, analytical instrumentation and packaging systems are responding with innovative technologies that meet a company needs.

In advanced level of pharmaceutical companies may target on genomics and truly personalised medicine to enable us to receive therapy individually customised to our own genetic background.

In short, they must now look beyond their running production efficiently and rethink their whole approach to it and demand a level of innovation that matches the recent changes in the pharmaceutical landscape.

Community Development

Over the years, social media has been a highly sensitive area for life sciences companies, which are often bound by strict marketing and FDA regulations. But some companies are beginning to experiment with the new medium. For example, drug maker Sanofi has emerged as a social media leader by building a Facebook community for diabetes sufferers who connect online to share their experiences with the disease.

O’Riordan said, "These types of forums can help our clients better understand their customers’ perspectives, experiences and problems, while also providing information on current treatment trends and patterns,”

In the other direction, feedback from clients and suppliers offers opportunities for product improvement.

Pharmaceutical industries in Bangladesh may follow this way by building a community for growing awareness among the peoples and getting better responses from the patients.

Market Development

Marketing is the key point of success for a pharmaceutical company. More advancement in marketing will lead to be more achievement for a company. There are four main areas where digital developments will drive value for pharma companies, building on what we see as the key components of digital success—an ability to deliver more personalized patient care, engage more fully with physicians and patients, use data to drive superior insight and decision making, and transform business processes to provide real-time responsiveness.

So we can say, developments in manufacturing, marketing, research and development (R&D), and IT will shape the future of pharma sector in Bangladesh.

Related Posts

Anticancer Drugs in Bangladesh
Biotech Products in Bangladesh Pharma sector


Post a Comment

Note: Only a member of this blog may post a comment.